ArticlePloS one2018
Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition.Frontiers in endocrinology · 2024Pooled it
- Systematic review ofFrontiers in aging neuroscience · 2023Pooled it
- Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia.Frontiers in aging neuroscience · 2023Pooled it
- Women's midlife: the front line of Alzheimer prevention.The Journal of clinical investigation · 2026Review
- Sex hormones in the nucleus incertus: a novel perspective on sex/gender differences in memory and mood dysfunction in Alzheimer's disease.Frontiers in aging neuroscience · 2026Review
- Article
- Article
- Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.Frontiers in dementia · 2023Article
- Sex and menopause impactScientific reports · 2022Article
- Gender-specific clinical risk scores incorporating blood pressure variability for predicting incident dementia.Journal of the American Medical Informatics Association : JAMIA · 2022Observational
- Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer's disease.Frontiers in aging neuroscience · 2022Review
- 17-β Estradiol Rescued Immature Rat Brain against Glutamate-Induced Oxidative Stress and Neurodegeneration via Regulating Nrf2/HO-1 and MAP-Kinase Signaling Pathway.Antioxidants (Basel, Switzerland) · 2021Article
- The peri-menopause in a woman's life: a systemic inflammatory phase that enables later neurodegenerative disease.Journal of neuroinflammation · 2020Review
- Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality.Nutrients · 2019Review
- Relationship between serum IL-1β and insomnia and liver depression in patients with perimenopausal non-organic sleep disorder.Experimental and therapeutic medicine · 2019Article
Corrections and comments
- Erratum for
Authors and funding
13 authors.
Funding
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0185926.].
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.